Skip to main content

Abstract

Objective

Schizophrenia is characterized by widespread cognitive deficits that reflect distributed dysfunction across multiple cortical regions. Here the authors examined the relationship between lower- and higher-level dysfunction within the auditory domain using the event-related brain potentials mismatch negativity (MMN) and P300.

Method

Event-related brain potentials were obtained from 50 schizophrenia patients and 21 healthy subjects in two conditions: a standard condition employing fixed differences between standard tones and pitch deviants and a novel individualized condition employing tones matched to each individual's tone-discrimination threshold. The relationship among measures was assessed by multiple regression analysis and structural equation modeling.

Results

In the standard fixed-deviance condition, schizophrenia patients showed deficits of large effect size in generation of MMN (d>1.26) and P300 (d=1.08) relative to comparison subjects. Assessment of deviance-detection thresholds showed that patients required significantly elevated tone-matching thresholds relative to comparison subjects (d=0.97). When tone differences were individually adjusted to equate tone-matching performance across groups, the groups no longer differed significantly in MMN amplitude during deviant pitch tones, and the degree of deficit in P300 generation was significantly reduced. In both multiple regression analysis and structural equation modeling, MMN and diagnostic group were significant independent predictors of reduced P300 amplitude. MMN generation was well explained (>90% variance) by dipoles seeded within the bilateral auditory cortex.

Conclusions

These findings confirm and extend previous reports of impaired basic sensory processing in schizophrenia and demonstrate significant contributions of early sensory processing dysfunction to higher-order cognitive impairments. Overall, the findings support distributed, hierarchical models of cognitive impairment in schizophrenia, consistent with glutamatergic and other widespread neurochemical models of the disorder.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 818 - 827
PubMed: 20478875

History

Accepted: 14 January 2009
Received: 9 March 2009
Published online: 1 July 2010
Published in print: July 2010

Authors

Affiliations

David I. Leitman, Ph.D.
Pejman Sehatpour, M.D., Ph.D.
Daniel C. Javitt, M.D., Ph.D.

Notes

Received March 9, 2009; revisions received Oct. 1, Nov. 8, and Dec. 9, 2009; accepted Jan. 14, 2010. From the Schizophrenia Research Center, Nathan S. Kline Institute for Psychiatric Research; the Program in Cognitive Neuroscience, The City College of the City University of New York; the Neuropsychiatry Program-Department of Psychiatry, University of Pennsylvania, Philadelphia; and the Departments of Psychiatry and Neuroscience, NYU Langone School of Medicine, New York. Address correspondence and reprint requests to Dr. Javitt, Director: Program in Cognitive Neuroscience and Schizophrenia, Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Rd., Orangeburg, NY 10962; [email protected] (e-mail).

Competing Interests

Dr. Javitt holds intellectual property rights for use of NMDA agonists—including glycine, D-serine, and glycine transport inhibitors—in the treatment of schizophrenia. He is a major shareholder in Glytech, Inc. and Amino Acids Solutions, Inc., and within the past year has served as a paid consultant to Sepracor, Solvay, Sanofi, Lundbeck, and Pfizer. Dr. Foxe receives grant support from Unilever Corp. The remaining authors report no financial relationships with commercial interests.

Funding Information

Supported in part by NIMH grants NRSA F1-MH-067339 (Dr. Leitman) and R01 MH-049334 (Dr. Javitt) and by the NYU Conte Center for Schizophrenia Research (P50 MH-086385).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Full Text

View Full Text

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share